INTRODUCTION INTRODUCTION INTRODUCTION INTRODUCTION INTRODUCTION
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the incidence and mortality from colorectal cancer [1, 2] . Indomethacin (IN), a NSAID, is related with the decrease of incidence rate and mortality rate of colon cancer when administered on a long-term basis. Previous studies demonstrated that IN inhibit growth and metastasis of tumor by non-selectively inhibiting cyclooxygenase (COX) [3] [4] [5] . It is found in recent years that inhibiting cell proliferation and inducing cell apoptosis is another mechanism by which IN inhibit tumor [6] [7] [8] . In this study, Western blot analysis was employed to examine the effect of IN on the expression of cyclin-dependent kinase (CDK) CDK 2 , CDK 4 and cyclindependent kinase inhibitor (CKI) p21
WAF1/CIP1 in wild-type p53 transfected colon cancer cell line SW480 (wtp53/ SW480), so as to provide experimental evidence to elucidate the anti-tumor mechanism of IN.
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Reagents
p53-Mutated human colon cancer SW480 cell line was purchased from ATCC. wtp53/SW480 was SW480 transfected with wild-type p53 allele according to Bampoe and Shetty ascribed previously [9, 10] , wtp53/PLXSN recombinant plasmid was kindly provided by Dr. Zhou Xiao, wtp53/PLXSN plasmid was transfected into SW480 cells. Eight-hundred milligrams per liter of G418 was added 48 h after transfection and kept at 200 mg/L concentration for G418 resistance screening. G418-resistant clones of wtp53/ SW480 cells were selected randomly. The cells were amplified in media with 200 mg/L G418. The blank plasmid PLXSN was transfected into SW480 cells for the control. Total RNA was extracted from wtp53/SW480 cells, SW480 cells and blank plasmid transfected SW480 cells using Trizol isolation kit according to the manufacturer's instructions. cDNA was synthesized from total RNA in 20 µL reaction mixture using a RT-PCR kit (GIBICO-BRL), including 25 mmol/L MgCl 24 µL, 10× RT buffer 2 µL, 10 mmol/L dNTP 2 µL, Rnasin 40 U, AMV 200 U, Oligo(dT) 151 µL. Cell culture SW480 and wtp53/SW480 were maintained in RPMI-1640 medium containing 10% inactive fetal bovine serum, 50 IU/L penicillin and 50 µg/L streptomycin at 37 under an atmosphere of 5 mL/L CO 2 .
Drug treatment
In experimental group, the cells were treated with IN at final concentration of 100, 200, 400 and 600 µmol/L; in the control group, the cells were treated only with medium or DMSO. The cells were harvested in 24 h treatment.
Protein extraction
The cells were washed twice with PBS, followed by 5 000 r/min centrifugation at 4 for 10 min, lysed with lysis buffer (50 mmol/L Tris-Cl pH 6.8, 1 mmol/L EDTA, 2%SDS, 5 mmol/L DTT, 10 mmol/L PMSF) on ice, denaturation at boiling water, renaturation on ice, disruption with ultrasound for 30 s, 12 000 g centrifugation again for 30 min and discard supernatant. The protein concentration was analyzed with Protein Assay Reagent Kit, and aliquots of cell lysates were stocked at -70 .
Western blotting
Aliquots of cell lysates containing 80 µg of total proteins were separated by SDS-polyacrylamide gel for 2-3 h, and transferred to nitrocellulose filters. The filters were blocked with PBS-T buffer containing 5% skimmed milk for 4-6 h, incubated with rabbit anti-CDK 2 (1:200), anti-CDK 4 (1:200), anti-p21 WAF1/CIP1 (1:500) polyclonal antibodies respectively for 1 h, then the filters washed with PBS-T for 4 min×15 min and followed by the addition of horseradish peroxidaselinked goat anti-rabbit IgG and ECL visualization of the bands.
For internal control, the same filters were washed with PBS-T for 30 min×3 min, followed by incubation with mouse anti-β-actin in 5% skimmed milk (1:10 000 dilution) for 1 h, incubation with horseradish peroxidase-linked goat anti-mouse IgG for 1 h, and ECL visualization of the bands. 
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Inhibition of tumor cells proliferation and induction of tumor cells apoptosis are associated with the blocking of the programmed progression of cell cycle [11] [12] [13] . NSAIDs inhibit proliferation and induce apoptosis in human colorectal cancer cells in vitro [14] . Our previous studies have protein. To eliminate the error caused by the volume of protein, β-actin protein was used as control, for its stable expression and abundant content in the same class of cells which could ensure the reliability of objective protein and β-actin protein.
The results of the study showed that: IN down-regulated the expression of CDK 2 and CDK 4 protein, especially caused dramatic decreases in Cdk 4 activities, which leads to a G 1 phase cell cycle arrest, in the meantime, up-regulated p21
protein in wtp53/SW480 cells, in a dose-dependent manner within a certain range of concentration; while it had no effect on the expression of CDK 2 , CDK 4 and p21
protein in SW480 cells, suggesting that the existence of wild-type p53 was required for the down-regulation of CDK 2 and CDK 4 expression by IN [15] . Therefore, we can speculate that up-regulation of p21 WAF1/CIP1 protein expression inhibits CDK 2 and CDK 4 expression as well as their activity, p21
being an important physiological regulator of CdK 4 complexes [16] , it increased with the augment of IN concentration, most evidently at 400 µmol/L, and reduced to a basic level at 600 µmol/L, the most effective being 400 µmol/L; the drop of CDK 2 and CDK 4 activity in turn decreases the activity of CDK 2 or CDK 4 complex and induces cell cycle arrest in G 2 phase, indicating the effect of IN on colon cancer cells transfected with wild-type p53, namely wtp53/SW480 cells, being to induce cell apoptosis depending on p53 in a dose-dependent manner. Based on the results of previous studies and current research, we conclude IN induces cell cycle arrest in G 2 phase in a p53-dependent way and inhibits cell proliferation in a p53-p21 WAF1/CIP1 dependent way.
As it is well known, cell cycle is dominated by a regulatory network. A cell proliferation-regulating system composed of cyclins, CDKs and CKIs, can accelerate the progression of cell cycle and thus promote cell proliferation. The main regulatory point to start cell cycle is in G 1 phase, the core in cell cycle regulation are cyclin and CDK [17] , and the formation of CyclinD/CDK 4 and CyclinE/CDK 2 is the rate-limiting step for progression of G 1 phase. Activation of CDK 2 and CDK 4 can yield many cell cycle related proteins, thus prompting progression from G 1 phase to S phase [18, 19] ; p21 WAE1/CIP1 , a major member of CIKs family, which is closely related with growth and differentiation of tumor cells, is an extensive inhibitor for CDK, it can bind and block Cyclin/CDK complex and thus inhibit the activity of CDK 2 and CDK 4 , stop the progression of cell cycle and induce G 2 phase arrest [11] . Wild-type p53 and p21 WAF1/CIP1 , which are functionally related, are the inhibitors for CDKscyclin complex [20, 21] , so abnormality in the p53 or p21 WAF1/CIP1 gene will lead to abnormal cell proliferation [22] [23] [24] . There is a high frequency of p53 mutation in colon cancer, and mutant p53 can neither stop cell growth nor induce cell apoptosis, therefore, colon cancer is resistant to conventional chemotherapy drugs and not sensitive to assistant treatment of DNA damage. Transfection of wild-type p53 together with chemotherapy and radiotherapy can evidently induce apoptosis, reduce the dosage of chemotherapy and radiotherapy and decrease side effects [25, 26] . Thus, it is held by some that for many tumors with p53 mutation or deletion which has a very poor sensitivity to radiotherapy and chemotherapy, gene transfection should be considered to enhance the sensitivity [27] [28] [29] . So the tumor-suppressing protein p53 mediate chemotherapy drugs induced apoptosis through the regulatory effect of p21 protein on cell cycle progression [30, 31] . In vitro experiments have proved that IN inhibits cell proliferation, alters cell cycle and arrests G 1 phase possibly through down-regulating CDK 2 and CDK 4 protein expression and up-regulating p21 WAF1/CIP1 protein, giving elementary experimental evidence to elucidate the mechanism by which IN inhibits colon cancer, but much needs to be done to elucidate the anti-tumor mechanism of IN in detail [32] and on a network basis.
